AstraZenca Pharma India Ltd. | ASTRAZEN | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Net Income |
| 438 | 727 | 1,140 | 1,271 |
Cash flow Operating Act... |
| 88 | 550 | 874 | 1,048 |
Investments in PPE |
| -63 | -187 | -142 | -77 |
Cash flow Investing Act... |
| -94 | 43 | -1,708 | 1,730 |
Dividend Paid |
| 0 | 0 | 30 | 50 |
Cash flow Financing Act... |
| 0 | 0 | -64 | -90 |
Cash at beginning of period |
| 1,146 | 1,140 | 1,732 | 835 |
Cash at end of period |
| 1,140 | 1,732 | 835 | 3,523 |
Free Cash Flow |
| 25 | 363 | 732 | 971 |